Creo Medical Group PLC

10.62pAs of Sun 8 Nov 2026, 12:00 UTC
LSE:CREOHealthcare
Ctry United Kingdom
PE (Fwd) •••
TSR 10Y CAGR (18.67%)
Div yield —
ROE (29.15%)
Medical Devices
Beta (5Y) 0.95
PE TTM —
TSR TTM (5.56%)
Mkt cap £47.63M
ROIC (39.15%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
10p
(2.27%)
(17.71%)
Hold 10|1|9|3|12
4Q25
1Q26
2Q26
3Q26
Earnings per share£
0.28
0.31
0.31
0.32
23.45%
26.65%
16.53%
11.49%
Revenue£M
4.075
4.065
4.114
4.178
4.20%
2.10%
(1.99%)
0.40%
Peers (US$64.75M)
Cap (US$)
PE
140.6M
42.87x
21.38M
56.41x
65.37M
—
Capital
TTM
5Y
10Y
Leveragex
1.863
0.852
0.586
EBIT/Intx
1.276
0.222
0.223
Own earn%
(76.49)
(5.82)
(5.68)
Sh yield%
37.10
39.28
39.46
Owners
Insiders/Inst%
9.24
75.28
Short interest%
3.94
SBC / revenue%
1.06
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
25
Op margin range%
23–26
$1 testx
—
Incr. ROIC%
6